InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA.
View Top Employees from Inflarx Gmbh| Website | http://www.inflarx.de |
| Ticker | IFRX |
| Revenue | $248000 |
| Funding | $89 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2007 |
| Address | Winzerlaer St 2, Jena, Thuringia 07745, DE |
| Phone | +49 4936 41508180 |
| Fax | +49 4936 41508181 |
| Industry | Pharmaceuticals, Health Care, Healthcare, Medical, Biotechnology, Pharmaceutical, Drug Manufacturing & Research, Therapeutics |
| Competitors | Allakos Inc, Biokine Therapeutics Ltd., Compass Therapeutics Inc., Sagimet Biosciences, Visterra Inc. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Inflarx Gmbh employee's phone or email?
Inflarx Gmbh Questions
The Inflarx Gmbh annual revenue was $248000 in 2023.
Kofi Boaten is the Head Supply Quality and CTS of Inflarx Gmbh.
3 people are employed at Inflarx Gmbh.
Inflarx Gmbh is based in Jena, Thuringia.
The NAICS codes for Inflarx Gmbh are [3254, 325, 32, 32541].
The SIC codes for Inflarx Gmbh are [28, 283].
Top Inflarx Gmbh Employees
-
53
-
3
-
